Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Viemed Healthcare (VMD) EBIAT (2018 - 2025)

Historic EBIAT for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to $3.6 million.

  • Viemed Healthcare's EBIAT fell 781.05% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.0 million, marking a year-over-year increase of 3366.47%. This contributed to the annual value of $11.4 million for FY2024, which is 1138.34% up from last year.
  • Per Viemed Healthcare's latest filing, its EBIAT stood at $3.6 million for Q3 2025, which was down 781.05% from $3.2 million recorded in Q2 2025.
  • Over the past 5 years, Viemed Healthcare's EBIAT peaked at $4.4 million during Q4 2024, and registered a low of $967000.0 during Q2 2022.
  • Moreover, its 5-year median value for EBIAT was $2.3 million (2023), whereas its average is $2.5 million.
  • In the last 5 years, Viemed Healthcare's EBIAT plummeted by 9193.28% in 2021 and then skyrocketed by 17668.25% in 2023.
  • Over the past 5 years, Viemed Healthcare's EBIAT (Quarter) stood at $4.1 million in 2021, then plummeted by 40.35% to $2.4 million in 2022, then skyrocketed by 42.62% to $3.5 million in 2023, then grew by 27.24% to $4.4 million in 2024, then fell by 18.63% to $3.6 million in 2025.
  • Its EBIAT was $3.6 million in Q3 2025, compared to $3.2 million in Q2 2025 and $2.7 million in Q1 2025.